109 related articles for article (PubMed ID: 29204645)
21. Suppression of c‑FLIPL promotes JNK activation in malignant melanoma cells.
Tian F; Hu Y; Sun X; Lu G; Li Y; Yang J; Tao J
Mol Med Rep; 2016 Mar; 13(3):2904-8. PubMed ID: 26847085
[TBL] [Abstract][Full Text] [Related]
22. Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma.
Halait H; Demartin K; Shah S; Soviero S; Langland R; Cheng S; Hillman G; Wu L; Lawrence HJ
Diagn Mol Pathol; 2012 Mar; 21(1):1-8. PubMed ID: 22306669
[TBL] [Abstract][Full Text] [Related]
23. A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice.
Schlereth SL; Iden S; Mescher M; Ksander BR; Bosch JJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5965-73. PubMed ID: 26377082
[TBL] [Abstract][Full Text] [Related]
24. T1799A BRAF mutations in conjunctival melanocytic lesions.
Goldenberg-Cohen N; Cohen Y; Rosenbaum E; Herscovici Z; Chowers I; Weinberger D; Pe'er J; Sidransky D
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3027-30. PubMed ID: 16123397
[TBL] [Abstract][Full Text] [Related]
25. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation.
Lee LM; Seftor EA; Bonde G; Cornell RA; Hendrix MJ
Dev Dyn; 2005 Aug; 233(4):1560-70. PubMed ID: 15968639
[TBL] [Abstract][Full Text] [Related]
26. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
27. B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.
Ugurel S; Thirumaran RK; Bloethner S; Gast A; Sucker A; Mueller-Berghaus J; Rittgen W; Hemminki K; Becker JC; Kumar R; Schadendorf D
PLoS One; 2007 Feb; 2(2):e236. PubMed ID: 17311103
[TBL] [Abstract][Full Text] [Related]
28. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
[TBL] [Abstract][Full Text] [Related]
29. Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes.
Lake SL; Jmor F; Dopierala J; Taktak AF; Coupland SE; Damato BE
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5598-604. PubMed ID: 21693616
[TBL] [Abstract][Full Text] [Related]
30. Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents.
Westekemper H; Freistuehler M; Bornfeld N; Steuhl KP; Scheulen M; Hilger RA
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):279-84. PubMed ID: 22782301
[TBL] [Abstract][Full Text] [Related]
31. Establishment of multi-site infection model in zebrafish larvae for studying Staphylococcus aureus infectious disease.
Li YJ; Hu B
J Genet Genomics; 2012 Sep; 39(9):521-34. PubMed ID: 23021551
[TBL] [Abstract][Full Text] [Related]
32. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
[TBL] [Abstract][Full Text] [Related]
33. Low incidence of minor BRAF V600 mutation-positive subclones in primary and metastatic melanoma determined by sensitive and quantitative real-time PCR.
Kristensen T; Clemmensen O; Hoejberg L
J Mol Diagn; 2013 May; 15(3):355-61. PubMed ID: 23499336
[TBL] [Abstract][Full Text] [Related]
34. Melanoma genome evolution across species.
Kansler ER; Verma A; Langdon EM; Simon-Vermot T; Yin A; Lee W; Attiyeh M; Elemento O; White RM
BMC Genomics; 2017 Feb; 18(1):136. PubMed ID: 28173755
[TBL] [Abstract][Full Text] [Related]
35. Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish.
Ren J; Liu S; Cui C; Ten Dijke P
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28518096
[TBL] [Abstract][Full Text] [Related]
36. Patient-derived tumor xenograft model to guide the use of BRAF inhibitors in metastatic melanoma.
Guerreschi P; Scalbert C; Qassemyar A; Kluza J; Ravasi L; Huglo D; Martinot-Duquennoy V; Formstecher P; Marchetti P; Mortier L
Melanoma Res; 2013 Oct; 23(5):373-80. PubMed ID: 23852164
[TBL] [Abstract][Full Text] [Related]
37. Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy.
Cao J; Heijkants RC; Jochemsen AG; Dogrusöz M; de Lange MJ; van der Velden PA; van der Burg SH; Jager MJ; Verdijk RM
Oncotarget; 2017 Aug; 8(35):58021-58036. PubMed ID: 28938534
[TBL] [Abstract][Full Text] [Related]
38. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish.
Haldi M; Ton C; Seng WL; McGrath P
Angiogenesis; 2006; 9(3):139-51. PubMed ID: 17051341
[TBL] [Abstract][Full Text] [Related]
39. Dissecting Oncogenic RAS Signaling in Melanoma Development in Genetically Engineered Zebrafish Models.
Badrock AP; Hurlstone A
Methods Mol Biol; 2021; 2262():411-422. PubMed ID: 33977492
[TBL] [Abstract][Full Text] [Related]
40. Vemurafenib.
Garbe C; Abusaif S; Eigentler TK
Recent Results Cancer Res; 2014; 201():215-25. PubMed ID: 24756795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
